Abstract
Chronic low back pain (CLBP) remains a leadingglobal cause of pain and disability, withdegenerative disc disease (DDD) historicallyimplicated as the predominant aetiology. Recentresearch has introduced the concept ofvertebrogenic back pain (VLBP), a conditionwhere vertebral endplates contribute significantlyto CLBP. The Basi-vertebral nerve (BVN), whichinnervates the vertebral endplates, has emerged asa key target for therapeutic intervention in VLBP.While BVN ablation (BVNA) has shown promise,its integration into clinical practice remains in theearly stages. Supported by robust pre-clinical andclinical evidence, the American Society of Painand Neuroscience (ASPN) has recognized theneed for evidence-based guidelines to guidepatient selection for BVNA. The ASPN’sworkgroup, which reviewed available literature,concluded that BVNA offers Level A evidence,confirming its substantial benefit in appropriatelyselected individuals
Recommended Citation
Almahdi, Basil
(2025)
"Basi- Vertebral Nerve (BVN) Ablation As an Emerging Treatment for Vertebrogenic Lower Back Pain,"
Iraqi Postgraduate Medical Journal: Vol. 24:
Iss.
1, Article 1.
DOI: 10.52573/ipmj.2025.186789
Available at:
https://ipmj.researchcommons.org/journal/vol24/iss1/1
DOI
10.52573/ipmj.2025.186789